4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037484
Chief Medical Officer sold 51,914 shares at an average $22.01 ($1,142,375)
- Chief Medical Officer acquired 87,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…